Toxic Tort · Glyphosate

Roundup case review.

Sign exclusive Roundup retainers from claimants who used the herbicide regularly and were later diagnosed with Non-Hodgkin lymphoma. Pre-qualified for exposure window, diagnosis date, and medical documentation.

Free, confidential review No fee unless you win Reviewed within 24 hours
Active prospect intake

Roundup case review

Tell us about your case and a specialist will reach out within one business day.

By submitting this form, you are agreeing by your electronic signature to the Terms and Conditions and Privacy Policy that Claimified and/or its partners may contact you regarding their services by phone or email. You provide your express written consent to receive phone calls (including autodialed and/or pre-recorded/artificial voice calls) and email using automated dialing system at the phone number and email address you provided, even if it is a wireless number, regardless of whether you are on any Federal or state DNC ("Do Not Call") and/or DNE ("Do Not Email") list or registry. In addition, you understand and acknowledge that you are over 18 years of age and your consent is not required as a condition. Your consent can be revoked through any reasonable means. Your telephone company may impose additional charges on subscriber for messages (required for SMS) and there is no obligation to enroll. (Please note the licensed agents are not connected with or endorsed by the U.S. government or any federal program.)

✓

Thank you.

Your case review has been submitted. A specialist will contact you within one business day.

About this campaign

What firms need to know about Roundup cases.

Roundup

Roundup is the consumer brand name for glyphosate-based herbicides manufactured by Monsanto and now Bayer. Long-term occupational and residential exposure has been linked to Non-Hodgkin lymphoma and related blood cancers, with a multi-district litigation underway in the Northern District of California.

Claimified runs paid search, paid social, and broadcast media for Roundup nationwide. Every inbound is screened for years of exposure, application setting (commercial vs. residential), and lymphoma diagnosis records before any retainer is sent.

Qualification criteria

How claimants are pre-screened before they reach your firm.

Every Roundup lead is vetted on identity, eligibility window, exposure history, and medical fit so your intake team only sees viable cases.

01

Diagnosis confirmation

We confirm a Non-Hodgkin lymphoma or related diagnosis with date, ICD code, and documenting provider before the case advances.

02

Exposure history

Claimant must demonstrate sustained Roundup or Ranger Pro use — typically two-plus years of regular handling.

03

Statute of limitations

Each case is checked against the relevant state statute, with priority routing for time-sensitive filings.

Risk-free delivery

Scale Roundup acquisition without scaling risk.

Plug into the same engine that took one firm from $9K to $3M in monthly Roundup spend while producing more than 9,400 signed cases.

Book a strategy call

More campaigns

Other active mass tort categories.